Research
E Mazzone, S Perera, A Neti, D Chen, H Al-Saffar, A Thomson, M Perera, M Lawrentschuk, D MurphyRe: [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.European Urology. 2024 Apr 12:S1470-2045(24)00135-9
E Mazzone, S Perera, A Neti, D Chen, H Al-Saffar, A Thomson, M Perera, M Lawrentschuk, D Murphy
Re: [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
European Urology. 2024 Apr 12:S1470-2045(24)00135-9

Dr. Marlon Perera
Dr. Marlon Perera is an Australian-trained, award-winning urology surgeon who specialises in robotic surgery and uro-oncology. Dr. Perera has worldwide experience, having completed a PhD (Urology) and a prized-accredited ‘Society of Urologic Oncology’ (SUO) fellowship at one of the world’s best and most prestigious cancer centres – Memorial Sloan Kettering Cancer Center in New York City. He provides comprehensive care in the treatment of prostate cancer, kidney masses and cancers, bladder cancer, kidney stones, and voiding dysfunction.